Educational Activity

Posts about this type

JCP
Developments in Major Depressive Disorder Therapy
DELETE CME Institute Showcase

August 14, 2023

Among the greatest unmet needs in MDD is for effective pharmacotherapies for patients who do not respond to first- and second-line antidepressant medications. After decades of muted progress, alternatives...
Michael E. Thase
JCP
Evolving Research on Postpartum Depression Pathophysiology and Treatment
DELETE CME Institute Showcase

August 14, 2023

Research on neuroactive steroids reveals their role in perinatal depression, leading to development of novel therapeutics. These emerging treatments hold promise for faster onset and lasting effects.  
Kristina M. Deligiannidis, Rubiahna Vaughn
JCP
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
DELETE CME Institute Showcase

August 9, 2023

While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory...
Jeffrey H. Newcorn
JCP
Emerging Perspectives in Addiction Psychiatry
DELETE CME Institute Showcase

August 9, 2023

FDA-approved medications and early intervention for people with substance use disorders should be encouraged as early as possible to optimize patient outcomes and life expectancy.
Ayana Jordan
JCP
Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management
DELETE CME Institute Showcase

August 7, 2023

Next generation therapeutics that work well, are better tolerated, and lead to improved outcomes may offer a different treatment approach for patients with schizophrenia.
Leslie Citrome, Jonathan M. Meyer
JCP
Timely Diagnosis of Alzheimer Disease
Educational Activity

August 1, 2022

Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in...
Anna D. Burke, Danielle Goldfarb
JCP
Treatment of Early-Stage Alzheimer Disease
Educational Activity

August 1, 2022

Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what,...
Anna D. Burke, Danielle Goldfarb
JCP
DELETE eView

October 26, 2021

Seizure clusters take a toll on patients’ emotional wellbeing, work, and quality of life. Learn from experts about new rescue treatments.
Kamil Detyniecki, Patricia Penovich
JCP
DELETE eReport

October 12, 2021

Can you recognize risk factors for tardive dyskinesia? Are you familiar with diagnostic criteria? Do you regularly assess patients for the condition? Are you knowledgeable about using new medications...
Christoph U. Correll, Leslie Citrome
JCP
DELETE eReport

July 13, 2021

Dr Krystal describes a new paradigm for managing insomnia in which clinicians can select interventions that best target the sleep problem of each patient. The result is an improved...
Andrew D. Krystal
JCP
DELETE eReport

July 6, 2021

Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
Joseph F. Goldberg
JCP
DELETE eReport

June 29, 2021

What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
Robert L. Findling
JCP
DELETE eReport

June 29, 2021

Do your older patients experience insomnia? Dr Krystal offers general considerations and specific data related to managing insomnia in older adults, including tolerability of treatment options.
Andrew D. Krystal
JCP
DELETE Audio Summary

May 11, 2021

Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.
Danielle Goldfarb
JCP
DELETE eReport

April 27, 2021

Antipsychotics can be used in the short term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and...
Clive Ballard
JCP
Educational Activity

March 23, 2021

Can a patient-centered approach to treatment be adopted for patients with schizophrenia? Can these patients take part in shared decision-making? Follow along as Dr Harvey shares his expertise.
Philip D. Harvey
JCP
Educational Activity

March 23, 2021

Patients may be more willing to accept some adverse effects than others. Dr Kane offers advice on addressing side effects that prevent patients from maintaining their medication adherence.
John M. Kane
JCP
Educational Activity

March 16, 2021

Insomnia is often comorbid with psychiatric, medical, and neurologic disorders. Follow along as Dr Rosenberg discusses the bidirectional relationship between insomnia disorder and frequently co-occurring conditions.
Russell P. Rosenberg
JCP
Educational Activity

March 16, 2021

To diagnose insomnia disorder, how do you conduct an effective interview with patients? What assessment tools do you use? Review the evaluation process with an expert.
Russell P. Rosenberg
JCP
Educational Activity

December 1, 2020

After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy "wears off." How can you increase their ON time? In this...
Rajesh Pahwa, Stuart H. Isaacson
JCP
Educational Activity

December 1, 2020

What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients' family members? Dr Ballard considers these topics in...
Clive Ballard
JCP
Educational Activity

December 1, 2020

Although clinicians are pressed for time, diligence in assessing for tardive dyskinesia in patients taking antipsychotics is crucial, especially now that treatment is available. In this brief CME activity,...
Andrew A. Nierenberg
JCP
DELETE eReport

November 3, 2020

Measurement-based care (MBC) has been found to be effective in patients with psychiatric conditions. In this CME activity, learn how Dr Joseph McEvoy employs MBC for patients with tardive...
Joseph P. McEvoy
JCP
DELETE eReport

November 3, 2020

Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
Andrew A. Nierenberg

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe